Health

CEO Of Twinlab, Naomi Whittel’s Premier book, GLOW15, is an instant New York Times and Wall Street Journal bestseller

CEO Of Twinlab, Naomi Whittel’s Premier book, GLOW15, is an instant New York Times and Wall Street Journal bestseller

New York, April 03, 2018 (GLOBE NEWSWIRE) —  – Glow15: A Science-Based Plan To Lose Weight, Revitalize Your Skin, and Invigorate Your Life (Houghton Mifflin Harcourt, March 6, 2018) has landed at #6 on The New York Time’s “” list, and #5 on The Wall Street Journal’s “.” Founder of Reserveage Nutrition, CEO of Twinlab Consolidated Holdings, and now author […]

Nightstar Therapeutics Reports 2017 Financial Results and Business Highlights

Nightstar Therapeutics Reports 2017 Financial Results and Business Highlights

– Recent initiation of STAR phase 3 trial in Choroideremia – – Begins 2018 with a cash position over $129 million – LEXINGTON, Mass. and LONDON, April 03, 2018 (GLOBE NEWSWIRE) — Nightstar Therapeutics plc (NASDAQ:), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today reported financial results for the year ended December 31, 2017 and […]

Curetis erhält US De Novo Zulassung der Gesundheitsbehörde FDA für Unyvero System und Unyvero LRT Kartusche zur Diagnose von Infektionen der unteren Atemwege

Curetis erhält US De Novo Zulassung der Gesundheitsbehörde FDA für Unyvero System und Unyvero LRT Kartusche zur Diagnose von Infektionen der unteren Atemwege               – Erste FDA-Zulassung eines molekulardiagnostischen Multiplex-Tests für diese Indikation               – Vermarktungsbeginn in den USA in diesem Quartal erwartet Amsterdam, Niederlande, San Diego, USA, und Holzgerlingen, Deutschland, 03. April 2018, 22:45 Uhr MESZ — Curetis N.V. (das “Unternehmen” […]

Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge

Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge Amsterdam, the Netherlands, San Diego, CA, USA, and Holzgerlingen, Germany, April 03, 2018, 15:45 am EDT – Curetis N.V. (the “Company” and, together with Curetis USA Inc. and Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, announced today that the […]

EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes

EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes

Clinical Results Presented at the Southeastern Section of the American Urological Association Confirms HIFU‘s Safety, Efficacy and Benefits for Patients‘ Quality Of Life LYON, FRANCE, AUSTIN, TX — APRIL 3, 2018 – EDAP TMS (Nasdaq: EDAP) today announced that preliminary results of the first U.S. clinical cohort study of focal therapy, using the company‘s system for partial-gland ablation demonstrated promising […]